Biomarin Pharmaceutical Inc
$12.08B- Market cap
- $12.88B
- Debt
- +$505.32M
- Cash
- −$1.31B
Capital structure 96% equity / 4% debt · EV / Revenue 3.75x · EV / EBITDA 21.37x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
BMRN · current priceP/E 36.97x
$66.55Latest market snapshot
Implied fair value · at TTD's multiple
$28.9056.6% below market
1.80 BMRN EPS (TTM)×16.06x TTD P/E=$28.90
Market $66.55Implied $28.90
TTD · current priceP/E 16.06x
$14.45Latest market snapshot
Implied fair value · at BMRN's multiple
$33.28130.3% above market
0.90 TTD EPS (TTM)×36.97x BMRN P/E=$33.28
Market $14.45Implied $33.28